<DOC>
	<DOC>NCT01649700</DOC>
	<brief_summary>The study is to investigate the efficacy and safety of autologous transplantation of adipose-derived mesenchymal stem cells in patients with the sequelae caused by severe brain injury.</brief_summary>
	<brief_title>Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Subject has a confirmed diagnosis of a brain AVM (arteriovenous malformation). Strokelike symptoms, including paralysis, caused by brain AVM hemorrhage. Subject's modified Rankin scale (mRS) grades IV~V. Ages between 20~40 years. Estimated life expectancy must be greater than 2 months. Signed informed consent from the subject. Pregnancy test positive. Subject infected with hepatitis C, HIV or syphilis. Subject not suitable for liposuction surgery. Subject not eligible for PET or MRI. Subject enrolled in any other cell therapy studies within the past 30 days. Subject deemed to be not suitable for the study by the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>